Figure 1.
NRM and REL cumulative incidence estimates (36-month) from a competing risk model, estimated separately for both conditioning regimens. STANDARD myeloablative and RIC.
NRM and REL cumulative incidence estimates (36-month) from a competing risk model, estimated separately for both conditioning regimens. STANDARD myeloablative and RIC.
